­­The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH

Blood - United States
doi 10.1182/blood.2019002600
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Double-Hit B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2011English

Double‐hit Lymphoma: So What?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma With Combined TP53 Mutation and MIR34A Methylation: Another &Ldquo;double Hit” Lymphoma With Very Poor Outcome?

Oncotarget
Oncology
2014English

Drug Therapy for Double-Hit Lymphoma

Drugs in Context
Molecular MedicinePharmacology
2019English

Immunohistochemical Double Hit Score Enhances NCCN-IPI and Is Associated With Detrimental Outcomes in Refractory or Relapsing Patients With Diffuse Large B Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Double Hit and Double Expressors in Lymphoma: Definition and Treatment

Cancer
Cancer ResearchOncology
2018English

Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy